Sandimmune Injection Cyclosporine USP 50 Mg ML Sandimmune Oral Solution Cyclosporine Oral Solution USP Sandimmune Soft Gelatin Capsules Cy.pdf

Last update : 1 month ago

"Sandimmune® Injection (cyclosporine, USP) 50 mg/mL; Sandimmune® Oral Solution (cyclosporine oral solution, USP); Sandimmune® Soft Gelatin Capsules (cy" is owned and hosted by fda.gov, this file has been downloaded 114 times, the last time was in 2025-03-12.
FDA/CDER is the creator of 050573Orig1s035,050574Orig1s043,050625Orig1s049ltr.pdf.
The pdf has been created in 2012-08-30, if you want to preview or download it, just click the link below.

  Download
Title Sandimmune® Injection (cyclosporine, USP) 50 mg/mL; Sandimmune® Oral Solution (cyclosporine oral solution, USP); Sandimmune® Soft Gelatin Capsules (cy
File Name 050573Orig1s035,050574Orig1s043,050625Orig1s049ltr.pdf - 226.28 KB
Pages 11 pages
Owner fda.gov
Author FDA/CDER
Creation date 12 years ago
Nb of downloads 114

If you are the owner and you want to remove this file from our databse, please contact us, we will remove it within 24 hours.

If "Sandimmune Injection cyclosporine USP 50 mg mL Sandimmune Oral Solution cyclosporine oral solution USP Sandimmune Soft Gelatin Capsules cy" does not meet your expectations, we invite you to take a look at the similar files below :

Related files to Sandimmune Injection cyclosporine USP 50 mg mL Sandimmune Oral Solution cyclosporine oral solution USP Sandimmune Soft Gelatin Capsules cy

SANDIMMUNE Injection Cyclosporine Injection USP 50 Mg ML SANDIMMUNE Oral Solution Cyclosporine Oral Solution USP 100 Mg ML SANDIMMUNE Soft
050573Orig1s041,050574Orig1s051,050625Orig1s055ltr.pdf

Sandimmune Cyclosporine USP Injection Oral Solution Soft Gelatin Capsules
050573Orig1s039,050574Orig1s047,050625Orig1s053ltr.pdf

PATIENT INFORMATION And INSTRUCTIONS FOR USE Epinephrine Injection USP 0 3 Mg Auto Injector Epinephrine Injection USP 0 3 Mg One Dose Of 0 3 Mg
Epinephrine Auto-Injector_PPI_IFU.pdf

Development And Validation Of A HPLC Method For The Determination Of Cyclosporine A In New Bioadhesive Nanoparticles For Oral Administration
development-and-validation-of-a-hplc-method-for-the-determination-of-cyclosporine-a-in-new-bioadhesive-nanoparticles-for.pdf

RyClora Oral Solution USP PI Rev 2
RyClora-Oral-Solution-USP-PI-Rev.-2.pdf

More files from fda.gov

Guidance For Industry 109 Effectiveness Of Anthelmintics Specific Recommendations For Equine VICH GL15 Final Guidance June 27 2002
Owner : fda.gov

RIM Tutorial For CEN TC251
Owner : fda.gov

Pediatric Expertise For Advisory Panels Guidance For Industry And FDA Staff
Owner : fda.gov

MEDICATION GUIDE CIPRO Sip Row Ciprofloxacin Hydrochloride
Owner : fda.gov

510 K Summary
Owner : fda.gov